Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Microorganisms|July 30, 2025
The Complete Genomes of <i>Microcystis ichthyoblabe</i> Kützing and <i>Microcystis protocystis</i> (Crow) Komárek & Anagnostidis Reveal the Complexity and Plasticity of <i>Microcystis</i> GenomesJina Kim, Hyaekang Kim, Jaeduk Goh, et al.
The Journal of Pathology|November 7, 2025
Transcriptomic profiling reveals the role of Hedgehog signaling as a biomarker and in the pathogenesis of Ménétrier's diseaseMiyoung Shin, Tryston T Gabriel, Fred Kwame Ofosu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2019
p27 transcriptionally coregulates cJun to drive programs of tumor progressionHyunho Yoon, Minsoon Kim, Kibeom Jang, et al.
Scientific Reports|February 10, 2026
Analytical and clinical validation of CancerMaster, an automated targeted NGS panel, for tumor-only precision oncologyJingmin Che, Woo Sun Kwon, Jaeyoung Kim, et al.
Biomaterials|September 4, 2013
In vivo fluorescence imaging for cancer diagnosis using receptor-targeted epidermal growth factor-based nanoprobeJu Hee Ryu, Miyoung Shin, Sun Ah Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 3, 2024
Increased GluK1 Subunit Receptors in Corticostriatal Projection from the Anterior Cingulate Cortex Contributed to Seizure-Like ActivitiesXu-Hui Li, Wantong Shi, Zhi-Xia Zhao, et al.
JCO Precision Oncology|September 11, 2020
CD33_PGx6_Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology GroupLata Chauhan, Miyoung Shin, Yi-Cheng Wang, et al.
Nature Communications|June 17, 2024
C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancerSeyedeh Fatemeh Razavipour, Hyunho Yoon, Kibeom Jang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531Jatinder K Lamba, Lata Chauhan, Miyoung Shin, et al.
Nature Communications|October 12, 2022
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancerChoong-Kun Lee, Sun Young Rha, Hyo Song Kim, et al.
Pageof 6